-
Teva calls on startups to Rise to the occasion with open innovation platform for 7 biopharma challenges
19 Nov 2025 22:09 GMT
Teva Pharmaceutical Industries is launching its first global … mentorship and funding,” Teva’s spokesperson told Fierce.
Teva throws down the … ," a representative for Teva explained in an emailed statement … performance in a Nov. 5 earnings release.
-
Why Teva Pharmaceutical Stock Rocked the Market Today
06 Nov 2025 06:24 GMT
… its third-quarter earnings report.
Teva Pharmaceutical Industries (TEVA +20.23%) … well-received quarterly earnings report. That increase … With those figures, Teva notched convincing beats … adjusted) net profit.
Teva Pharmaceutical Industries
Today's Change …
-
Teva's Innovative Portfolio Drives 11th Consecutive Quarter of Growth in Q3 2025; Increases 2025 Outlook for Austedo® and Non-GAAP EPS
05 Nov 2025 12:00 GMT
… . Net income attributable to Teva and diluted earnings per share in the … ;s website. About Teva Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is transforming into … net income attributable to Teva for diluted earnings per share:*
910
798 …
-
Johnson Controls, Babcock & Wilcox, Lemonade, Lumentum, Teva Pharmaceutical And Other Big Stocks Moving Higher On Wednesday
05 Nov 2025 17:07 GMT
… analyst estimates on both earnings and revenue.
The company … reported fourth-quarter adjusted earnings per share of $ … guidance on Tuesday.
Teva Pharmaceutical Industries Ltd (NYSE:TEVA) gained 21.5% … company beat third-quarter earnings and revenue estimates and …
-
Teva Pharma's Key Branded Drugs Fuel Strong Revenue Growth, Lifts Full-Year Profit Outlook
05 Nov 2025 16:50 GMT
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) reported its third- … olanzapine LAI.
Also Read: Teva, Viatris On Investor Watch … drug maker reported adjusted earnings of 78 cents, beating … .
Teva Pharmaceutical raised its fiscal year 2025 adjusted earnings from …
-
Teva’s Innovative Portfolio Drives 11th Consecutive Quarter of Growth in Q3 2025; Increases 2025 Outlook for Austedo® and Non-GAAP EPS
05 Nov 2025 14:26 GMT
… .
Net income attributable to Teva and diluted earnings per share in the … income attributable to Teva and non-GAAP diluted earnings per share in … within 24 hours on Teva’s website.
About Teva
Teva Pharmaceutical Industries Ltd. (NYSE and …
-
Teva beats analysts on Q3, raises guidance
05 Nov 2025 14:28 GMT
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has presented strong third … billion; and non-GAAP earnings per share of $2 … profit and adjusted EBITDA (earnings before interest, taxes, depreciation … to $910 million - earnings per share of $0 …
-
Teva Pharm third-quarter profit tops estimates as branded drugs gain
05 Nov 2025 14:04 GMT
JERUSALEM (Reuters) -Teva Pharmaceutical Industries reported on Wednesday a higher- … .48 billion.
Analysts had forecast earnings of 67 cents per share …
-
Teva jumps ahead of Q3 results
03 Nov 2025 15:52 GMT
The share price of Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) rose 8.1% … 33 billion, and non-GAAP earnings per share of $0. … out of 10 analysts covering Teva stock, nine are positive … will focus on what Teva management said about the …
-
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q2 2025 Earnings Call Transcript
31 Jul 2025 12:31 GMT
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q2 2025 Earnings Call Transcript July 30, 2025
Teva Pharmaceutical Industries Limited misses … on earnings …
About
© 1995-2025